405 related articles for article (PubMed ID: 9117541)
1. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse.
German DC; Nelson EL; Liang CL; Speciale SG; Sinton CM; Sonsalla PK
Neurodegeneration; 1996 Dec; 5(4):299-312. PubMed ID: 9117541
[TBL] [Abstract][Full Text] [Related]
2. Midbrain dopaminergic neurons in the mouse that contain calbindin-D28k exhibit reduced vulnerability to MPTP-induced neurodegeneration.
Liang CL; Sinton CM; Sonsalla PK; German DC
Neurodegeneration; 1996 Dec; 5(4):313-8. PubMed ID: 9117542
[TBL] [Abstract][Full Text] [Related]
3. Midbrain dopaminergic neurons in the mouse: co-localization with Calbindin-D28K and calretinin.
Liang CL; Sinton CM; German DC
Neuroscience; 1996 Nov; 75(2):523-33. PubMed ID: 8931015
[TBL] [Abstract][Full Text] [Related]
4. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
German DC; Dubach M; Askari S; Speciale SG; Bowden DM
Neuroscience; 1988 Jan; 24(1):161-74. PubMed ID: 3259295
[TBL] [Abstract][Full Text] [Related]
5. Increased midbrain dopaminergic cell activity following 2'CH3-MPTP-induced dopaminergic cell loss: an in vitro electrophysiological study.
Bernardini GL; Speciale SG; German DC
Brain Res; 1990 Sep; 527(1):123-9. PubMed ID: 1980838
[TBL] [Abstract][Full Text] [Related]
6. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: sparing of calbindin-D28k-containing cells.
German DC; Manaye KF; Sonsalla PK; Brooks BA
Ann N Y Acad Sci; 1992 May; 648():42-62. PubMed ID: 1353337
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice.
Kurosaki R; Muramatsu Y; Kato H; Watanabe Y; Imai Y; Itoyama Y; Araki T
Eur Neuropsychopharmacol; 2005 Jan; 15(1):57-67. PubMed ID: 15572274
[TBL] [Abstract][Full Text] [Related]
8. GSTpi expression in MPTP-induced dopaminergic neurodegeneration of C57BL/6 mouse midbrain and striatum.
Castro-Caldas M; Neves Carvalho A; Peixeiro I; Rodrigues E; Lechner MC; Gama MJ
J Mol Neurosci; 2009 Jun; 38(2):114-27. PubMed ID: 18792812
[TBL] [Abstract][Full Text] [Related]
9. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
10. Decreased susceptibility to oxidative stress underlies the resistance of specific dopaminergic cell populations to paraquat-induced degeneration.
McCormack AL; Atienza JG; Langston JW; Di Monte DA
Neuroscience; 2006 Aug; 141(2):929-937. PubMed ID: 16677770
[TBL] [Abstract][Full Text] [Related]
11. GM-1 ganglioside promotes the recovery of surviving midbrain dopaminergic neurons in MPTP-treated monkeys.
Herrero MT; Perez-Otaño I; Oset C; Kastner A; Hirsch EC; Agid Y; Luquin MR; Obeso JA; Del Rio J
Neuroscience; 1993 Oct; 56(4):965-72. PubMed ID: 7904332
[TBL] [Abstract][Full Text] [Related]
12. Diethyldithiocarbamate causes nigral cell loss and dopamine depletion with nontoxic doses of MPTP.
Walters TL; Irwin I; Delfani K; Langston JW; Janson AM
Exp Neurol; 1999 Mar; 156(1):62-70. PubMed ID: 10192777
[TBL] [Abstract][Full Text] [Related]
13. Injury and strain-dependent dopaminergic neuronal degeneration in the substantia nigra of mice after axotomy or MPTP.
Liu L; Hsu SS; Kalia SK; Lozano AM
Brain Res; 2003 Dec; 994(2):243-52. PubMed ID: 14642650
[TBL] [Abstract][Full Text] [Related]
14. Midbrain dopaminergic neurons in the mouse: computer-assisted mapping.
Nelson EL; Liang CL; Sinton CM; German DC
J Comp Neurol; 1996 Jun; 369(3):361-71. PubMed ID: 8743418
[TBL] [Abstract][Full Text] [Related]
15. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
[TBL] [Abstract][Full Text] [Related]
16. Catalpol attenuates MPTP induced neuronal degeneration of nigral-striatal dopaminergic pathway in mice through elevating glial cell derived neurotrophic factor in striatum.
Xu G; Xiong Z; Yong Y; Wang Z; Ke Z; Xia Z; Hu Y
Neuroscience; 2010 Apr; 167(1):174-84. PubMed ID: 20123001
[TBL] [Abstract][Full Text] [Related]
17. Midbrain dopaminergic neurons (nuclei A8, A9, and A10): three-dimensional reconstruction in the rat.
German DC; Manaye KF
J Comp Neurol; 1993 May; 331(3):297-309. PubMed ID: 8514911
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment.
Sugama S; Wirz SA; Barr AM; Conti B; Bartfai T; Shibasaki T
Neuroscience; 2004; 128(2):451-8. PubMed ID: 15350655
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
[TBL] [Abstract][Full Text] [Related]
20. Continuous subcutaneous infusion of apomorphine rescues nigro-striatal dopaminergic terminals following MPTP injection in mice.
Battaglia G; Busceti CL; Cuomo L; Giorgi FS; Orzi F; De Blasi A; Nicoletti F; Ruggieri S; Fornai F
Neuropharmacology; 2002 Mar; 42(3):367-73. PubMed ID: 11897115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
